ANI Pharmaceuticals To Present Data From SYNCHRONICITY Phase 4 Clinical Trial Of Fluocinolone Acetonide Intravitreal Implant In Patients With Chronic Non-Infectious Uveitis Affecting The Posterior Segment Of The Eye In Oral Presentation During Uveitis Subspecialty Day 2026 At The American Academy Of Ophthalmology Meeting On October 9

뉴스 본문을 불러오고 있어요.

ANI Pharmaceuticals To Present Data From SYNCHRONICITY Phase 4 Clinical Trial Of Fluocinolone Acetonide Intravitreal Implant In Patients With Chronic Non-Infectious Uveitis Affecting The Posterior Segment Of The Eye In Oral Presentation During Uveitis Subspecialty Day 2026 At The American Academy Of Ophthalmology Meeting On October 9 | 웨이프 WAPE

기사 요약

관련 종목

댓글 —